File | |
Title Alternative | 内因性NLRP3インフラマソーム阻害剤であるベータヒドロキシ酪酸の前頭前野への注入は、げっ歯類のうつ病モデルに抗うつ薬のような効果を示す
|
Authors |
Kajitani, Naofumi
Division of Neuropsychiatry, Department of Brain and Neuroscience, School of Medicine, Tottori University Faculty of Medicine
Researchers DB
|
Content Type |
Thesis or Dissertation
|
Link | |
Publisher-DOI | |
Text Version |
ETD
|
Rights | © 2020 The Authors.Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Society of NeuropsychoPharmacology.
|
Citation | Naofumi Kajitani,Masaaki Iwata,Akihiko Miura,Kyohei Tsunetomi,Takehiko Yamanashi,Ryoichi Matsuo,Tsuyoshi Nishiguchi,Saki Fukuda,Mayu Nagata,Midori Shibushita,Takahira Yamauchi,Shenghong Pu,Yukihiko Shirayama,Ken Watanabe,Koichi Kaneko. Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression. Neuropsychopaharmacology reports. 2020, , . https://doi.org/10.1002/npr2.12099.
|
Department |
Faculty of Medicine/Graduate School of Medical Sciences/University Hospital
|
Language |
English
|
Grant ID | 甲第935号
|
Granted Date | 2020/3/31
|
Degree Name |
博士(医学)
|
Grantor | 鳥取大学
|